While circulating levels of PYY 3-36 are frequently reduced in individuals with obesity 31,32,33,34,35 , these levels typically return to those detected in average-weight individuals following a reduction in body weight and/or gastric bypass surgery 32,33,35
A1C reductions were largely maintained over time
GLP-1 receptor agonists sit right at this intersection
Those with type 2 diabetes seeking both glycemic control and weight management find Mounjaro particularly valuable
Drugs including semaglutide (Ozempic and Wegovy), tirzepatide (Zepbound and Mounjaro) and liraglutide (Saxenda and Victoza) are proven to support weight loss, glucose control and other health concerns
SeekPeptides has analyzed the clinical trial data from both compounds extensively, and this guide breaks down everything researchers need to make an informed decision